On the stock market since 2011, it operates in the world of money and finance. Now — the numbers.
This is an established company with proven profits.
No real growth (3% a year). Red columns mark years that ended in a loss.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
The price looks reasonable next to what the company earns.
Clearly above the class average — a step short of the very top.
Clearly above the class average — a step short of the very top.
Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades below its recent peak — about 11% off the top. A pullback, not a collapse.
Over the last 3 years, sales grew about 11% a year on average.
It pays out $0.41 per share each year — regular cash for whoever holds the stock.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 10/100.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
On our five-subject report card, ARYVX sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: ARYVX is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.